Molecular characterisation of Chlamydia pneumoniae associated to atherosclerosis
نویسندگان
چکیده
منابع مشابه
Chlamydia pneumoniae and atherosclerosis.
OBJECTIVE To review the literature for evidence that chronic infection with Chlamydia pneumoniae is associated with atherosclerosis and acute coronary syndromes. DATA SOURCES MEDLINE and Institute of Science and Information bibliographic databases were searched at the end of September 1998. Indexing terms used were chlamydi*, heart, coronary, and atherosclerosis. Serological and pathological ...
متن کاملAtherosclerosis and Chlamydophila (chlamydia) Pneumoniae
The concept that atherosclerosis was induced by environmental factors such as smoking and high fat intake was perturbated when inflammation was found to be prominent in atherosclerotic lesions. Chlamydophila pneumoniae but also other microbes inducing chronic endothelial infections have been implicated, particularly cytomegalovirus (CMV) and the gastric pathogen Helicobacter pylori. Large sero-...
متن کاملRole of Chlamydia pneumoniae in atherosclerosis.
Cardiovascular disease, resulting from atherosclerosis, is a leading cause of global morbidity and mortality. Genetic predisposition and classical environmental risk factors explain much of the attributable risk for cardiovascular events in populations, but other risk factors for the development and progression of atherosclerosis, which can be identified and modified, may be important therapeut...
متن کاملChlamydia pneumoniae infection and atherosclerosis: methodological considerations.
Atherosclerosis: Methodological Considerations To the Editor: In contrast to several previously published studies,1–3 the one by Caligiuri et al4 failed to observe an accelerating effect of Chlamydia pneumoniae infection on atherosclerotic lesion development in apolipoprotein E–deficient mice. There are several critical differences in experimental design that likely account for these contrastin...
متن کاملSeroepidemiology in Chlamydia pneumoniae-- atherosclerosis association.
[1] van Hout BA, Simoons ML. Cost-effectiveness of HMG coenzyme reductase inhibitors. Whom to treat? Eur Heart J 2001; 22: 751–61. [2] Houterman S, Boshuizen HC, Verschuren VMM et al. Predicting cardiovascular risk in the elderly in different European countries. Eur Heart J 2002; 23: 294–300, doi:10.1053/euhj.2001.2898. [3] Clarke R, Lewington S, Youngman L, Sherliker P, Peto R, Collins R. Unde...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pathogens and Disease
سال: 2017
ISSN: 2049-632X
DOI: 10.1093/femspd/ftx039